Industry Voices and Cannabis News | Page 81 of 129 | Cannabiz

Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities

by Steve Jones April 17, 2024April 18, 2024

Neurotech International (NTI) has raised a further A$10 million through new and existing institutional investors as […]

LGP hits cashflow-positive milestone after strong end to year

by Steve Jones April 17, 2024April 17, 2024

Industry leaders urge medical bodies to ‘lean in’ to cannabis and not allow ‘bad actors’ to tarnish the medicine’s reputation

by Martin Lane April 9, 2024April 10, 2024

Long’s winding road to the top job

by Steve Jones April 4, 2024April 4, 2024

Althea announces job cuts worth A$1.5m with more savings to come

by Martin Lane March 28, 2024March 28, 2024

Bod administrators recommend Biortica deal

by Martin Lane March 28, 2024March 28, 2024

Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’

by Steve Jones March 27, 2024March 27, 2024

Cann Group eyes A$15m capital injection from New York-based investment firm

by Martin Lane March 25, 2024March 27, 2024

A race to the bottom for flower prices as suppliers fail to ‘walk the walk’ on terpene profiles

by Steve Jones March 25, 2024March 25, 2024

Cann Group CEO Peter Koetsier steps down

by Martin Lane March 21, 2024March 21, 2024